Clarification of Optimal Anticoagulation Through Genetics "COAG"

Completed

Phase 3 Results N/A

Summary of Purpose

Individuals taking warfarin often need frequent dose changes as the international normalized ratio (INR) gets too high or too low which could result in a higher risk of thromboembolism, bleeding and early discontinuation of a highly useful therapy. This study will compare two approaches to warfarin dosing to examine the utility of using genetic information for warfarin dosing.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 April 2016.

1 Sep 2009 6 Feb 2009 1 Apr 2013 1 Nov 2013 1 May 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts